1. Home
  2. ABBV
  3. ABBV News

Latest AbbVie Inc. (ABBV) News on June 30, 2025

3 Dividend Stocks to Double Up on Right Now
ABBV

Motley Fool

2 days ago

3 Dividend Stocks to Double Up on Right Now

Those who invested in AbbVie (NYSE:ABBV) five years ago are up 126%
ABBV

Simply Wall St.

2 days ago

Those who invested in AbbVie (NYSE:ABBV) five years ago are up 126%

Got $500? 2 Healthcare Stocks to Buy and Hold Forever
ABBV

Motley Fool

2 days ago

Got $500? 2 Healthcare Stocks to Buy and Hold Forever

AbbVie’s Elahere Market Expected to Skyrocket to $6B by 2034 in Ovarian Cancer Treatment
ABBV

Insider Monkey

3 days ago

AbbVie’s Elahere Market Expected to Skyrocket to $6B by 2034 in Ovarian Cancer Treatment

AbbVie (ABBV) Stock Dips While Market Gains: Key Facts
ABBV

Zacks

3 days ago

AbbVie (ABBV) Stock Dips While Market Gains: Key Facts

AbbVie Adds More Than $24B in 6 Months: How to Play ABBV Stock
ABBV

Zacks

3 days ago

AbbVie Adds More Than $24B in 6 Months: How to Play ABBV Stock

Incyte's New CEO Is A Dealmaking Machine. Will He Bring That Fervor To His New Role?
ABBV

Investor's Business Daily

4 days ago

Incyte's New CEO Is A Dealmaking Machine. Will He Bring That Fervor To His New Role?

Here's Why AbbVie (ABBV) is a Strong Momentum Stock
ABBV

Zacks

4 days ago

Here's Why AbbVie (ABBV) is a Strong Momentum Stock

Why New Incyte CEO Bill Meury Is Stoking Investors' M&A Hopes
ABBV

Investor's Business Daily

4 days ago

Why New Incyte CEO Bill Meury Is Stoking Investors' M&A Hopes

Rosalind Franklin University Helix 51 Company UP Oncolytics Secures Wisconsin Economic Development Matching Grant to Advance Oncolytic Virus Therapy for Brain Cancer
ABBV

PR Newswire

5 days ago

Rosalind Franklin University Helix 51 Company UP Oncolytics Secures Wisconsin Economic Development Matching Grant to Advance Oncolytic Virus Therapy for Brain Cancer

Elahere Market Opportunities and Strategies to 2034: Abbvie Secures European Approval for Elahere in Platinum-Resistant Ovarian Cancer
ABBV

GlobeNewswire

5 days ago

Elahere Market Opportunities and Strategies to 2034: Abbvie Secures European Approval for Elahere in Platinum-Resistant Ovarian Cancer

AbbVie (ABBV) Reports Positive Migraine Drug Results in Phase 3 Trial
ABBV

Insider Monkey

6 days ago

AbbVie (ABBV) Reports Positive Migraine Drug Results in Phase 3 Trial

Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
ABBV

Zacks

6 days ago

Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know

Will AbbVie's Growing Oncology Portfolio Aid Top-line Growth?
ABBV

Zacks

6 days ago

Will AbbVie's Growing Oncology Portfolio Aid Top-line Growth?

Age-Related Vision Dysfunction Market Research 2025-2035 | Kodiak Sciences, Genentech, and AbbVie Drive Innovations Through Advanced, Sustainable Solutions
ABBV

GlobeNewswire

6 days ago

Age-Related Vision Dysfunction Market Research 2025-2035 | Kodiak Sciences, Genentech, and AbbVie Drive Innovations Through Advanced, Sustainable Solutions

J&J's Drugs Get CHMP Recommendations for Blood Cancer Indications
ABBV

Zacks

7 days ago

J&J's Drugs Get CHMP Recommendations for Blood Cancer Indications

Is AbbVie the Best Dividend Stock in Big Pharma Today?
ABBV

Insider Monkey

10 days ago

Is AbbVie the Best Dividend Stock in Big Pharma Today?

LLY vs. ABBV: Which Pharma Powerhouse is the Better Bet?
ABBV

Zacks

10 days ago

LLY vs. ABBV: Which Pharma Powerhouse is the Better Bet?

ABBV

PR Newswire

10 days ago

AbbVie Declares Quarterly Dividend

AbbVie’s Phase III trial of atogepant for migraine meets primary goal
ABBV

Clinical Trials Arena

11 days ago

AbbVie’s Phase III trial of atogepant for migraine meets primary goal

AbbVie (NYSE:ABBV) Announces Positive Phase 3 Results for Migraine Drug Atogepant
ABBV

Simply Wall St.

12 days ago

AbbVie (NYSE:ABBV) Announces Positive Phase 3 Results for Migraine Drug Atogepant

GSK Stock Rises Almost 22% in 6 Months: Time to Buy, Sell or Hold?
ABBV

Zacks

12 days ago

GSK Stock Rises Almost 22% in 6 Months: Time to Buy, Sell or Hold?

ABBV

MT Newswires

12 days ago

AbbVie's Phase 3 Study of Atogepant in Migraine Prevention Achieves Primary, Secondary Endpoints

ABBV

PR Newswire

12 days ago

AbbVie Announces New Data Demonstrating Atogepant (QULIPTA® / AQUIPTA®) Achieves Superiority Across All Endpoints in Phase 3 Head-to-Head Study Compared to Topiramate for Migraine Prevention

AbbVie says Phase 3 Verona trial of venetoclax/azacitidine did not meet endpoint
ABBV

TipRanks

13 days ago

AbbVie says Phase 3 Verona trial of venetoclax/azacitidine did not meet endpoint

AbbVie (ABBV) Pipeline Bolstered as FDA Approves Mavyret Label Expansion for Hepatitis C
ABBV

Insider Monkey

14 days ago

AbbVie (ABBV) Pipeline Bolstered as FDA Approves Mavyret Label Expansion for Hepatitis C

AbbVie, ADARx Pharmaceuticals Partner to Develop Next-Gen siRNA Therapeutics
ABBV

Insider Monkey

14 days ago

AbbVie, ADARx Pharmaceuticals Partner to Develop Next-Gen siRNA Therapeutics

ABBV

MT Newswires

14 days ago

Sector Update: Health Care Stocks Retreat Late Afternoon

ABBV

MT Newswires

14 days ago

Sector Update: Health Care

ABBV

Clinical Trials Arena

14 days ago

EHA 2025: Genmab and AbbVie’s Epkinly outpaces BiTE rivals in r/r DLBCL trial

Here's Why AbbVie (ABBV) is a Strong Value Stock
ABBV

Zacks

14 days ago

Here's Why AbbVie (ABBV) is a Strong Value Stock

ABBV

MT Newswires

14 days ago

AbbVie Says Myelodysplastic Syndrome Phase 3 Trial Failed to Meet Primary Endpoint

ABBV

PR Newswire

14 days ago

AbbVie Provides Update on VERONA Trial for Newly Diagnosed Higher-Risk Myelodysplastic Syndromes

1 Cash-Producing Stock for Long-Term Investors and 2 to Steer Clear Of
ABBV

StockStory

15 days ago

1 Cash-Producing Stock for Long-Term Investors and 2 to Steer Clear Of

AbbVie Secures FDA Approval to Expand Mavyret’s Label
ABBV

Insider Monkey

17 days ago

AbbVie Secures FDA Approval to Expand Mavyret’s Label

FDA approves label expansion of AbbVie hepatitis C therapy
ABBV

Pharmaceutical Technology

18 days ago

FDA approves label expansion of AbbVie hepatitis C therapy

Senators Propose Ban on Drug Advertising to Consumers
ABBV

The Wall Street Journal

18 days ago

Senators Propose Ban on Drug Advertising to Consumers

ABBV

Investing.com

18 days ago

Lawmakers push to ban direct-to-consumer drug advertising, WSJ reports

AbbVie (NYSE:ABBV) Achieves FDA Approval for MAVYRET Label Expansion to Treat Pediatric Hepatitis C
ABBV

Simply Wall St.

18 days ago

AbbVie (NYSE:ABBV) Achieves FDA Approval for MAVYRET Label Expansion to Treat Pediatric Hepatitis C

AbbVie (ABBV) Gains As Market Dips: What You Should Know
ABBV

Zacks

19 days ago

AbbVie (ABBV) Gains As Market Dips: What You Should Know

FDA Expands AbbVie's Mavyret Label To Include Acute Hepatitis C Treatment (CORRECTED)
ABBV

Benzinga

19 days ago

FDA Expands AbbVie's Mavyret Label To Include Acute Hepatitis C Treatment (CORRECTED)

ABBV

MT Newswires

19 days ago

Sector Update: Health Care Stocks Rise in Afternoon Trading

ABBV

MT Newswires

19 days ago

AbbVie Receives FDA Label Expansion Approval for Mavyret to Treat Hepatitis C

U.S. FDA Approves Expanded Indication for AbbVie's MAVYRET® (Glecaprevir/Pibrentasvir) as First and Only Treatment for People with Acute Hepatitis C Virus
ABBV

PR Newswire

19 days ago

U.S. FDA Approves Expanded Indication for AbbVie's MAVYRET® (Glecaprevir/Pibrentasvir) as First and Only Treatment for People with Acute Hepatitis C Virus

Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
ABBV

Zacks

19 days ago

Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock

Have Skyrizi and Rinvoq Successfully Saved AbbVie From Humira LoE?
ABBV

Zacks

20 days ago

Have Skyrizi and Rinvoq Successfully Saved AbbVie From Humira LoE?

1 S&P 500 Stock with Competitive Advantages and 2 to Steer Clear Of
ABBV

StockStory

22 days ago

1 S&P 500 Stock with Competitive Advantages and 2 to Steer Clear Of

3 Stocks With Mouthwatering Dividends You Can Buy Right Now
ABBV

Motley Fool

22 days ago

3 Stocks With Mouthwatering Dividends You Can Buy Right Now

Challenges pharma companies face in push into US manufacturing
ABBV

Yahoo Finance Video

24 days ago

Challenges pharma companies face in push into US manufacturing

Can New Cancer Drug Emrelis Drive AbbVie's Oncology Franchise?
ABBV

Zacks

24 days ago

Can New Cancer Drug Emrelis Drive AbbVie's Oncology Franchise?

AbbVie (ABBV) Increases Despite Market Slip: Here's What You Need to Know
ABBV

Zacks

25 days ago

AbbVie (ABBV) Increases Despite Market Slip: Here's What You Need to Know

Billionaire Ken Griffin Just Bought More Shares of These Unstoppable Dividend Stocks
ABBV

Motley Fool

25 days ago

Billionaire Ken Griffin Just Bought More Shares of These Unstoppable Dividend Stocks

AbbVie (ABBV): Buy, Sell, or Hold Post Q1 Earnings?
ABBV

StockStory

a month ago

AbbVie (ABBV): Buy, Sell, or Hold Post Q1 Earnings?

Profit From the Silver Tsunami: Must-Watch Senior Care & Aging Stocks
ABBV

Zacks

a month ago

Profit From the Silver Tsunami: Must-Watch Senior Care & Aging Stocks

3 Cheap Dividend Growth Stocks to Buy Right Now
ABBV

Motley Fool

a month ago

3 Cheap Dividend Growth Stocks to Buy Right Now

ASCO25: AbbVie flexes ADC Phase I data as NSCLC market opportunity beckons
ABBV

Clinical Trials Arena

a month ago

ASCO25: AbbVie flexes ADC Phase I data as NSCLC market opportunity beckons

AbbVie Invites People Living with Migraine to Enter the Second Annual AbbVie Migraine Career Catalyst Award™ Contest to Support Their Professional Goals
ABBV

PR Newswire

a month ago

AbbVie Invites People Living with Migraine to Enter the Second Annual AbbVie Migraine Career Catalyst Award™ Contest to Support Their Professional Goals

AbbVie to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
ABBV

PR Newswire

a month ago

AbbVie to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

High Growth Tech Stocks To Watch In The US June 2025
ABBV

Simply Wall St.

a month ago

High Growth Tech Stocks To Watch In The US June 2025

ABBV

Argus Research

a month ago

Weekly Stock List

AbbVie (ABBV) Gains As Market Dips: What You Should Know
ABBV

Zacks

a month ago

AbbVie (ABBV) Gains As Market Dips: What You Should Know

AbbVie Partners with Chicago Cubs on "Striking Out Cancer"
ABBV

PR Newswire

a month ago

AbbVie Partners with Chicago Cubs on "Striking Out Cancer"

ABBV

MT Newswires

a month ago

Berenberg Adjusts Price Target on AbbVie to $170 From $195, Maintains Hold Rating

The Zacks Analyst Blog Highlights Berkshire Hathaway, AbbVie, Intuitive Surgical, Hamilton Beach Brands and AXIL Brands
ABBV

Zacks

a month ago

The Zacks Analyst Blog Highlights Berkshire Hathaway, AbbVie, Intuitive Surgical, Hamilton Beach Brands and AXIL Brands

AbbVie’s ADC win shows how pharma can break through in solid tumors
ABBV

Pharma Voice

a month ago

AbbVie’s ADC win shows how pharma can break through in solid tumors

Top Research Reports for Berkshire Hathaway, AbbVie & Intuitive Surgical
ABBV

Zacks

a month ago

Top Research Reports for Berkshire Hathaway, AbbVie & Intuitive Surgical

AbbVie Stock Down Around 13% in 3 Months: Time to Buy the Dip?
ABBV

Zacks

a month ago

AbbVie Stock Down Around 13% in 3 Months: Time to Buy the Dip?

AbbVie Inc. (ABBV)’s Pipeline Advances with Temab-A and ABBV-706, Shares Flat
ABBV

Insider Monkey

a month ago

AbbVie Inc. (ABBV)’s Pipeline Advances with Temab-A and ABBV-706, Shares Flat

AbbVie (NYSE:ABBV) Showcases Promising Phase 1 ADC Results For Advanced Cancers
ABBV

Simply Wall St.

a month ago

AbbVie (NYSE:ABBV) Showcases Promising Phase 1 ADC Results For Advanced Cancers

Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?
ABBV

Zacks

a month ago

Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?

ABBV

PR Newswire

a month ago

AbbVie Features New Data Across Difficult-to-Treat Solid Tumors and Blood Cancers at ASCO 2025, Highlighting Breadth and Depth of its Oncology Portfolio

Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1
ABBV

StockStory

a month ago

Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1

U.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result
ABBV

Motley Fool

a month ago

U.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result

Key Drivers Behind AbbVie’s (ABBV) Performance
ABBV

Insider Monkey

a month ago

Key Drivers Behind AbbVie’s (ABBV) Performance

AbbVie Inc. (ABBV) Scores Major Legal Victory as Illinois Court Shuts Down $63 Billion Allergan Shareholder Lawsuit
ABBV

Insider Monkey

a month ago

AbbVie Inc. (ABBV) Scores Major Legal Victory as Illinois Court Shuts Down $63 Billion Allergan Shareholder Lawsuit

AbbVie (NYSE:ABBV) Faces Legal Scrutiny Over Merger With Cerevel
ABBV

Simply Wall St.

a month ago

AbbVie (NYSE:ABBV) Faces Legal Scrutiny Over Merger With Cerevel

AbbVie and U of T Mississauga's SpinUp Announce Neuropeutics Inc as First AbbVie Biotech Innovators Award Recipient
ABBV

CNW Group

a month ago

AbbVie and U of T Mississauga's SpinUp Announce Neuropeutics Inc as First AbbVie Biotech Innovators Award Recipient

AbbVie (ABBV) has a Stable and Highly Profitable Business Model
ABBV

Insider Monkey

a month ago

AbbVie (ABBV) has a Stable and Highly Profitable Business Model

3 Value Stocks Facing Headwinds
ABBV

StockStory

a month ago

3 Value Stocks Facing Headwinds

2 Incredible Dividend Growth Stocks to Buy Now
ABBV

Motley Fool

a month ago

2 Incredible Dividend Growth Stocks to Buy Now

ABBV

MT Newswires

a month ago

Ameriprise Financial Initiates AbbVie at Buy

AbbVie (ABBV) Soared on Favorable Tailwinds
ABBV

Insider Monkey

a month ago

AbbVie (ABBV) Soared on Favorable Tailwinds

Pfizer Signs Experimental Drug Licensing Agreement With 3SBio
ABBV

Zacks

a month ago

Pfizer Signs Experimental Drug Licensing Agreement With 3SBio

The Zacks Analyst Blog Highlights Bayer, Novo Nordisk, GSK, Merck and AbbVie
ABBV

Zacks

a month ago

The Zacks Analyst Blog Highlights Bayer, Novo Nordisk, GSK, Merck and AbbVie

Don't Fall for These 3 Dividend Stocks: They May Have to Make a Cut.
ABBV

Motley Fool

a month ago

Don't Fall for These 3 Dividend Stocks: They May Have to Make a Cut.

3 Magnificent Stocks That Are Passive Income Machines
ABBV

Motley Fool

a month ago

3 Magnificent Stocks That Are Passive Income Machines

Jim Cramer On AbbVie: Makes “Sense To Start a Position in the Stock”
ABBV

Insider Monkey

a month ago

Jim Cramer On AbbVie: Makes “Sense To Start a Position in the Stock”

Pharma Stock Roundup: BAYRY Q1 Earnings, NVO & GSK's New Deals
ABBV

Zacks

a month ago

Pharma Stock Roundup: BAYRY Q1 Earnings, NVO & GSK's New Deals

1 Healthcare Stock to Keep an Eye On and 2 to Ignore
ABBV

StockStory

a month ago

1 Healthcare Stock to Keep an Eye On and 2 to Ignore

FDA awards cancer drug approvals to AbbVie and MSD
ABBV

Pharmaceutical Technology

2 months ago

FDA awards cancer drug approvals to AbbVie and MSD

AbbVie Secures FDA Nod for New ADC Drug Emrelis in Lung Cancer
ABBV

Zacks

2 months ago

AbbVie Secures FDA Nod for New ADC Drug Emrelis in Lung Cancer

AbbVie stakes $335M on a startup’s RNAi drugs
ABBV

BioPharma Dive

2 months ago

AbbVie stakes $335M on a startup’s RNAi drugs

AbbVie expands siRNA push with $335m ADARx deal
ABBV

Pharmaceutical Technology

2 months ago

AbbVie expands siRNA push with $335m ADARx deal

FDA approves Roche’s MET protein expression detecting assay for NSQ-NSCLC
ABBV

Medical Device Network

2 months ago

FDA approves Roche’s MET protein expression detecting assay for NSQ-NSCLC

Regeneron Upgraded as AbbVie Catches Policy Heat
ABBV

GuruFocus.com

2 months ago

Regeneron Upgraded as AbbVie Catches Policy Heat

FDA Fast-Tracks AbbVie's New Lung Cancer Therapy Emrelis For Tough Lung Cancer Cases
ABBV

Benzinga

2 months ago

FDA Fast-Tracks AbbVie's New Lung Cancer Therapy Emrelis For Tough Lung Cancer Cases

ABBV

MT Newswires

2 months ago

AbbVie Says US FDA Approved Emrelis for Lung Cancer Indication

US FDA approves AbbVie's drug for a type of lung cancer
ABBV

Reuters

2 months ago

US FDA approves AbbVie's drug for a type of lung cancer

U.S. FDA Approves EMRELIS™ (telisotuzumab vedotin-tllv) for Adults With Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC) With High c-Met Protein Overexpression
ABBV

PR Newswire

2 months ago

U.S. FDA Approves EMRELIS™ (telisotuzumab vedotin-tllv) for Adults With Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC) With High c-Met Protein Overexpression

AbbVie Inc. (ABBV): Among the Best Dividend Growth Stocks with High Yields
ABBV

Insider Monkey

2 months ago

AbbVie Inc. (ABBV): Among the Best Dividend Growth Stocks with High Yields

Share on Social Networks: